Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United Sta...

Filings

10-K / 10-Q / 8-K

Peers

TCRT / VCEL / KURA / BIOR.Q / VTVT

Quick Compare

Price History

1 Week

1 Month

3 Months

1 Year

5 Years

10 Years

- (-)

Data Explorer

Data could not be retrieved

Peer Benchmarks

Quote

Value

Size

Growth

Profit

	CRIS	Peers	Sector
Market Cap	19.643 M	61.925 M	64.173 M
Price % of 52 Week High	Premium	42.2%	62.0%
Dividend Yield	0.0%	0.0%	0.0%
Shareholder Yield	Premium	-21.8%	-0.7%
1 Year Price Total Return	-78.7%	-50.7%	-12.3%
Beta (5 Year)	-	1.07	0.64